Linda Mileshkin
The University of Melbourne(AU)Peter MacCallum Cancer Centre(AU)
Publications by Year
Research Areas
Endometrial and Cervical Cancer Treatments, Ovarian cancer diagnosis and treatment, Cancer Genomics and Diagnostics, Cancer Diagnosis and Treatment, PARP inhibition in cancer therapy
Most-Cited Works
- → Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial(2017)1,842 cited
- → Whole–genome characterization of chemoresistant ovarian cancer(2015)1,618 cited
- → Cervical cancer: A global health crisis(2017)1,179 cited
- → Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy(2020)790 cited
- → Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial(2018)604 cited
- → Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis(2016)502 cited